Skip to content

Primary Immunization of Pertussis, Diphtheria and Tetanus Containing Vaccine Optimization Strategy Study

Primary Immunization of Pertussis, Diphtheria and Tetanus Containing Vaccine Optimization Strategy Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121071
Enrollment
Unknown
Registered
2026-03-25
Start date
2022-01-13
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pertussis

Interventions

Control group:According to the vaccine package insert, administer three doses following either the 3-4-5 month schedule or the 2-3-4 month schedule.
Intervention Group:Administer three doses following the 2-4-6 month schedule.

Sponsors

Chinese Center for Disease Control and Prevention
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Healthy, resident infants who meet the age requirement of 2 months for the intervention group and 3 months for the control group on the day of enrollment; 2. Infants who have completed the required National Immunization Program vaccinations prior to reaching 2 months of age (intervention group) or 3 months of age (control group); 3. Parents or legal guardians of the infant have signed the informed consent form; 4. Parents or legal guardians of the infant are able to attend all scheduled visits and comply with all study procedures; 5. Axillary temperature <= 37.0°C.

Exclusion criteria

Exclusion criteria: 1. Infants who have previously received vaccines containing acellular DTP components, Hib vaccines, or their combination vaccines; 2. Neonates born at less than 37 weeks of gestation or with a birth weight of 37.0°C; 7. Other conditions.

Design outcomes

Primary

MeasureTime frame
Seroconversion proportion;

Secondary

MeasureTime frame
Antibody level;

Countries

China

Contacts

Public ContactYin Zundong

Chinese Center for Disease Control and Prevention

yinzd@chinacdc.cn+86 135 2005 6303

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 4, 2026